|
⚲
|
| Keyboard |
| Charles Clarvit | |
|---|---|
| Firm | |
| Address | c/o Agenebio, Inc 1101 E 33rd Street, Suite C310 Baltimore, MD 21218 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Agenebio Inc | 021-267885 | Director | 0.5 M of 3.0 M |
||
| Agenebio Inc | 021-233693 | Director | 0.4 M of 0.9 M |
||
| Agenebio Inc | 021-226687 | Director | 4.1 M of 10.0 M |
||
| Vinci Financial Venture Fund Onshore LP | 021-221139 | Executive Officer | 25.0 M | ||
| FQR Alternatives II LP | 021-70290 | Executive Officer | 617.3 M | ||
| Q-BLK Equity Edge Portfolio L P | 021-70289 | Executive Officer | 82.5 M | ||
| Q-Blk ARS III LLC | 021-68438 | Executive Officer | 375.5 M | ||
| BlackRock Appreciation Strategy Fund LLC | 021-42905 | Executive Officer | 3,581.1 M | ||
| Q-BLK Appreciation Fund LP | 021-74271 | Executive Officer | 286.8 M | ||